Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (181-190 of 250) with videos related to

Pageof 25
Sort By:
Vaccines|April 30, 2021
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine CandidateXuelan Liu, Xinyue Chang, Dominik Rothen, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2006
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adultsThomas M Kündig, Gabriela Senti, Gabriel Schnetzler, et al.
Journal of Virology|April 14, 2004
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3Dominique Sirena, Benjamin Lilienfeld, Markus Eisenhut, et al.
European Journal of Immunology|December 1, 2019
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen densityConnie B Gilfillan, Chensu Wang, Mona O Mohsen, et al.
Molecular Immunology|March 29, 2008
Identification of Ly-6K as a novel marker for mouse plasma cellsCaroline E von Allmen, Monika Bauer, Klaus Dietmeier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic painTill A Röhn, William T Ralvenius, Jolly Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1Carsten Gründemann, Monika Bauer, Oliver Schweier, et al.
Frontiers in Immunology|February 7, 2022
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle ImmunizationXinyue Chang, Pascal Krenger, Caroline C Krueger, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritisIsabell S von Loga, Aadil El-Turabi, Luke Jostins, et al.
Pageof 25

Showing results (181-190 of 250) with videos related to

Sort By:
Pageof 25
Vaccines|April 30, 2021
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine CandidateXuelan Liu, Xinyue Chang, Dominik Rothen, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2006
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adultsThomas M Kündig, Gabriela Senti, Gabriel Schnetzler, et al.
Journal of Virology|April 14, 2004
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3Dominique Sirena, Benjamin Lilienfeld, Markus Eisenhut, et al.
European Journal of Immunology|December 1, 2019
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen densityConnie B Gilfillan, Chensu Wang, Mona O Mohsen, et al.
Molecular Immunology|March 29, 2008
Identification of Ly-6K as a novel marker for mouse plasma cellsCaroline E von Allmen, Monika Bauer, Klaus Dietmeier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic painTill A Röhn, William T Ralvenius, Jolly Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1Carsten Gründemann, Monika Bauer, Oliver Schweier, et al.
Frontiers in Immunology|February 7, 2022
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle ImmunizationXinyue Chang, Pascal Krenger, Caroline C Krueger, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritisIsabell S von Loga, Aadil El-Turabi, Luke Jostins, et al.
Pageof 25